Key facts
- It has raised $20K; the latest was Accelerator/Incubator ($220K) in Sep 2025.
- Notable investors include Plug and Play Tech Center, Techstars.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Unephra
- ·The full record, as it builds
Funding rounds
No funding rounds for Unephra are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unephra
Developer of a non-contact, non-invasive technology designed for cardiovascular patients, especially those with heart failure or hypertension. The company's technology provides lifesaving monitoring services and helps lower medical expenses using proprietary technology, along with offering various features such as portable, machine-learning-based proprietary sensors and more, enabling hospitals to get quality equipment for patients.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2023
- Employees
- 3
- Website
- unephra.com/
- Ownership
- Privately Held (backing)
Unephra doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unephra shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unephra in its N-PORT filings yet. We sweep new filings monthly.